Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders

Nanomaterials provide enormous opportunities to overcome the limitations of conventional ocular delivery systems, such as low therapeutic efficacy, side effects due to the systemic exposure, or invasive surgery. Apart from the more common ocular disorders, there are some genetic diseases, such as cy...

Full description

Bibliographic Details
Main Authors: Elena K. Schneider-Futschik, Felisa Reyes-Ortega
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/8/1157
_version_ 1797522448466313216
author Elena K. Schneider-Futschik
Felisa Reyes-Ortega
author_facet Elena K. Schneider-Futschik
Felisa Reyes-Ortega
author_sort Elena K. Schneider-Futschik
collection DOAJ
description Nanomaterials provide enormous opportunities to overcome the limitations of conventional ocular delivery systems, such as low therapeutic efficacy, side effects due to the systemic exposure, or invasive surgery. Apart from the more common ocular disorders, there are some genetic diseases, such as cystic fibrosis, that develop ocular disorders as secondary effects as long as the disease progresses. These patients are more difficult to be pharmacologically treated using conventional drug routes (topically, systemic), since specific pharmacological formulations can be incompatible, display increased toxicity, or their therapeutic efficacy decreases with the administration of different kind of chemical molecules. Magnetic nanoparticles can be used as potent drug carriers and magnetic hyperthermia agents due to their response to an external magnetic field. Drugs can be concentrated in the target point, limiting the damage to other tissues. The other advantage of these magnetic nanoparticles is that they can act as magnetic resonance imaging agents, allowing the detection of the exact location of the disease. However, there are some drawbacks related to their use in drug delivery, such as the limitation to maintain efficacy in the target organ once the magnetic field is removed from outside. Another disadvantage is the difficulty in maintaining the therapeutic action in three dimensions inside the human body. This review summarizes all the application possibilities related to magnetic nanoparticles in ocular diseases.
first_indexed 2024-03-10T08:29:32Z
format Article
id doaj.art-b39f05a2ee8b420c96244553adb2c588
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T08:29:32Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-b39f05a2ee8b420c96244553adb2c5882023-11-22T09:13:28ZengMDPI AGPharmaceutics1999-49232021-07-01138115710.3390/pharmaceutics13081157Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular DisordersElena K. Schneider-Futschik0Felisa Reyes-Ortega1Department of Biochemistry & Pharmacology, Faculty of Medicine, School of Biomedical Sciences, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, AustraliaVisual Quality Research Group, Department of Ophthalmology, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital and University of Cordoba, 14004 Cordoba, SpainNanomaterials provide enormous opportunities to overcome the limitations of conventional ocular delivery systems, such as low therapeutic efficacy, side effects due to the systemic exposure, or invasive surgery. Apart from the more common ocular disorders, there are some genetic diseases, such as cystic fibrosis, that develop ocular disorders as secondary effects as long as the disease progresses. These patients are more difficult to be pharmacologically treated using conventional drug routes (topically, systemic), since specific pharmacological formulations can be incompatible, display increased toxicity, or their therapeutic efficacy decreases with the administration of different kind of chemical molecules. Magnetic nanoparticles can be used as potent drug carriers and magnetic hyperthermia agents due to their response to an external magnetic field. Drugs can be concentrated in the target point, limiting the damage to other tissues. The other advantage of these magnetic nanoparticles is that they can act as magnetic resonance imaging agents, allowing the detection of the exact location of the disease. However, there are some drawbacks related to their use in drug delivery, such as the limitation to maintain efficacy in the target organ once the magnetic field is removed from outside. Another disadvantage is the difficulty in maintaining the therapeutic action in three dimensions inside the human body. This review summarizes all the application possibilities related to magnetic nanoparticles in ocular diseases.https://www.mdpi.com/1999-4923/13/8/1157ocular disordersocular cancercystic fibrosismagnetic nanoparticlestherapeutic agentsmagnetic diagnosis agents
spellingShingle Elena K. Schneider-Futschik
Felisa Reyes-Ortega
Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
Pharmaceutics
ocular disorders
ocular cancer
cystic fibrosis
magnetic nanoparticles
therapeutic agents
magnetic diagnosis agents
title Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
title_full Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
title_fullStr Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
title_full_unstemmed Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
title_short Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
title_sort advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders
topic ocular disorders
ocular cancer
cystic fibrosis
magnetic nanoparticles
therapeutic agents
magnetic diagnosis agents
url https://www.mdpi.com/1999-4923/13/8/1157
work_keys_str_mv AT elenakschneiderfutschik advantagesanddisadvantagesofusingmagneticnanoparticlesforthetreatmentofcomplicatedoculardisorders
AT felisareyesortega advantagesanddisadvantagesofusingmagneticnanoparticlesforthetreatmentofcomplicatedoculardisorders